JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AVGX
4976
Defiance Daily Target 2X Long AVGO ETF
AVGX
$225M
| $377K | ﹤0.01% |
+11,614
| New | +$265K |
2024 Q4
0 quarters
|
|
4977
Waldencast
WALD
$112M
| $376K | ﹤0.01% |
93,561
+50,311
| +116% | +$177K |
2023 Q2
6 quarters
|
|
4978
LiveOne
LVO
$36.1M
| $375K | ﹤0.01% |
25,507
+22,229
| +678% | +$194K |
2018 Q2
26 quarters
|
|
4979
Intuitive Machines
LUNR
$2.37B
| $375K | ﹤0.01% |
20,645
+8,041
| +64% | +$89.1K |
2023 Q2
6 quarters
|
|
|
THRD
4980
DELISTED
Third Harmonic Bio
THRD
| $372K | ﹤0.01% |
36,147
+22,735
| +170% | +$283K |
2022 Q4
8 quarters
|
|
4981
Fulcrum Therapeutics
FULC
$282M
| $372K | ﹤0.01% |
79,120
-108,043
| -58% | -$399K |
2019 Q3
21 quarters
|
|
4982
Sigma Lithium
SGML
$1.02B
| $371K | ﹤0.01% |
33,053
+32,812
| +13,615% | +$429K |
2022 Q1
11 quarters
|
|
|
EAOR
4983
DELISTED
iShares ESG Aware Growth Allocation ETF
EAOR
| $370K | ﹤0.01% |
11,809
+11,772
| +31,816% | +$376K |
2024 Q2
2 quarters
|
|
4984
Franklin International Core Dividend Tilt Index ETF
DIVI
$2.65B
| $370K | ﹤0.01% |
12,336
+2,509
| +26% | +$78.6K |
2023 Q2
6 quarters
|
|
4985
Vanguard ESG US Corporate Bond ETF
VCEB
$1.17B
| $369K | ﹤0.01% |
5,959
-2,772
| -32% | -$175K |
2023 Q3
5 quarters
|
|
4986
OR Royalties Inc
OR
$6.46B
| $369K | ﹤0.01% |
20,402
+3,455
| +20% | +$67.2K |
2024 Q2
2 quarters
|
|
4987
Global X S&P 500 Covered Call ETF
XYLD
$3.4B
| $369K | ﹤0.01% |
8,809
-4,343
| -33% | -$182K |
2022 Q1
11 quarters
|
|
4988
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$735M
| $367K | ﹤0.01% |
7,310
-545
| -7% | -$28.6K |
2023 Q3
5 quarters
|
|
4989
CSP Inc
CSPI
$76.3M
| $366K | ﹤0.01% |
22,800
| – | – |
2017 Q3
29 quarters
|
|
4990
TFS Financial
TFSL
$4.72B
| $366K | ﹤0.01% |
29,152
+506
| +2% | +$6.73K |
2017 Q4
28 quarters
|
|
4991
i3 Verticals
IIIV
$257M
| $366K | ﹤0.01% |
15,877
+6,035
| +61% | +$142K |
2018 Q3
25 quarters
|
|
4992
CALL
Restaurant Brands International
QSR
$24.4B
| $365K | ﹤0.01% |
+5,600
| New | +$388K |
2024 Q4
0 quarters
|
|
|
VSDM
4993
Vanguard Short Duration Tax-Exempt Bond ETF
VSDM
$919M
| $364K | ﹤0.01% |
+4,863
| New | +$366K |
2024 Q4
0 quarters
|
|
4994
State Street SPDR NYSE Technology ETF
XNTK
$2.13B
| $362K | ﹤0.01% |
1,795
+400
| +29% | +$81.6K |
2020 Q3
17 quarters
|
|
4995
Frontier Group Holdings
ULCC
$1.43B
| $362K | ﹤0.01% |
50,902
+31,492
| +162% | +$197K |
2021 Q2
14 quarters
|
|
4996
Biote Corp
BTMD
$33M
| $362K | ﹤0.01% |
58,517
+41,086
| +236% | +$239K |
2023 Q2
6 quarters
|
|
4997
Clarus
CLAR
$132M
| $361K | ﹤0.01% |
80,090
+13,415
| +20% | +$60.2K |
2017 Q1
31 quarters
|
|
4998
State Street SPDR Portfolio TIPS ETF
SPIP
$1B
| $360K | ﹤0.01% |
14,243
-13,451
| -49% | -$346K |
2021 Q2
14 quarters
|
|
|
PAMT
4999
PAMT Corp
PAMT
$256M
| $360K | ﹤0.01% |
21,951
+16,736
| +321% | +$291K |
2016 Q4
32 quarters
|
|
5000
Invesco KBW High Dividend Yield Financial ETF
KBWD
$359M
| $359K | ﹤0.01% |
24,475
+12,426
| +103% | +$187K |
2020 Q1
19 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.